BioRestorative Therapies Inc (BRTX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioRestorative Therapies Inc (BRTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8090
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment for chronic lumbar disc diseases such as bulging and herniated discs. Its ThermoStem program develops brown fat stem cell-based therapy which is used for the treatment of type 2 diabetes, obesity, and other metabolic disorders. BRT provides identification and treatment of first stem cell population isolated from a particular brown fat depot in humans. The company operates in the US. BRT is headquartered in Melville, New York, the US.

BioRestorative Therapies Inc (BRTX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 11
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 12
BioRestorative Therapies Enters into Research Agreement with Pfizer 13
BioRestorative Therapies Enters Into R&D Agreement With Rohto Pharma 14
BioRestorative Therapies Enters into Agreement with Japanese pharma 15
BioRestorative Therapies Enters Into Research Agreement With University of Utah 16
Licensing Agreements 17
BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 17
Equity Offering 18
BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 18
BioRestorative Therapies to Raise up to USD4 Million in Public Offering of Shares and Warrants 19
BioRestorative Therapies Completes Private Placement Of Shares For US$0.5 Million 21
Debt Offering 22
BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 22
BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 23
BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 24
BioRestorative Therapies Inc – Key Competitors 25
BioRestorative Therapies Inc – Key Employees 26
BioRestorative Therapies Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Corporate Communications 28
Jul 25, 2018: BioRestorative Therapies Appoints Jason M. Lipetz to its Scientific Advisory Board 28
Jan 22, 2018: BioRestorative Therapies Appoints Adam D. Bergstein as Senior Vice President, Planning and Business Development 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRestorative Therapies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 11
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 12
BioRestorative Therapies Enters into Research Agreement with Pfizer 13
BioRestorative Therapies Enters Into R&D Agreement With Rohto Pharma 14
BioRestorative Therapies Enters into Agreement with Japanese pharma 15
BioRestorative Therapies Enters Into Research Agreement With University of Utah 16
BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 17
BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 18
BioRestorative Therapies to Raise up to USD4 Million in Public Offering of Shares and Warrants 19
BioRestorative Therapies Completes Private Placement Of Shares For US$0.5 Million 21
BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 22
BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 23
BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 24
BioRestorative Therapies Inc, Key Competitors 25
BioRestorative Therapies Inc, Key Employees 26
BioRestorative Therapies Inc, Subsidiaries 27

List of Figures
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BioRestorative Therapies Inc (BRTX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hargreaves Lansdown PLC:企業の戦略・SWOT・財務情報
    Hargreaves Lansdown PLC - Strategy, SWOT and Corporate Finance Report Summary Hargreaves Lansdown PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Scynexis Inc (SCYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs. The company provides pipeline products such as SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis …
  • Ache Laboratorios Farmaceuticos SA-製薬・医療分野:企業M&A・提携分析
    Summary Ache Laboratorios Farmaceuticos SA (Ache) is a drug company that offers generic products. The company provides prescription, prescription free, generic, dermatological, dermocosmetic drugs, nutraceuticals and probiotic products. Its activities include research, development, production, distr …
  • Danaher Corporation:企業の戦略・SWOT・財務情報
    Danaher Corporation - Strategy, SWOT and Corporate Finance Report Summary Danaher Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Enterprise Rent-A-Car Company:企業の戦略・SWOT・財務分析
    Enterprise Rent-A-Car Company - Strategy, SWOT and Corporate Finance Report Summary Enterprise Rent-A-Car Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • HeartSciences:医療機器:M&Aディール及び事業提携情報
    Summary HeartSciences, formerly Heart Test Laboratories Inc, is a medical device company that offers cardiac care products. The company develops, manufactures and markets cardiac testing tools for the early detection of heart disease. It offers MyoVista, a screening tool used to determine the presen …
  • nLife Therapeutics SL:製薬・医療:M&Aディール及び事業提携情報
    Summary nLife Therapeutics SL (nLife Therapeutics) is a biopharmaceutical company that discovers and develops cell specific oligonucleotides as therapeutic agents for the treatment of central nervous system and neuromuscular disorders. The company’s lead candidate includes NLF-PD-1233, an oligonucle …
  • Arsenal Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Arsenal Medical Inc (Arsenal) is a platform technology company that develops novel therapeutic polymer based foams. The company’s products include in-situ forming materials, in-situ forming polymeric foam and in-situ curing elastomeric polymer material. It offers in-situ forming materials to …
  • Haynes International Inc:企業の戦略・SWOT・財務分析
    Haynes International Inc - Strategy, SWOT and Corporate Finance Report Summary Haynes International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sichuan Kelun Pharmaceutical Co Ltd (002422)-製薬・医療分野:企業M&A・提携分析
    Summary Sichuan Kelun Pharmaceutical Co Ltd (Kelun) is a pharmaceutical company that manufactures and distributes IV Solutions. The company’s products include mannitol injection, glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’ …
  • Genomic Health Inc (GHDX):医療機器:M&Aディール及び事業提携情報
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …
  • Banco BPI SA:企業の戦略・SWOT・財務分析
    Banco BPI SA - Strategy, SWOT and Corporate Finance Report Summary Banco BPI SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Co-Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • Banco Bilbao Vizcaya Argentaria SA:戦略・SWOT・企業財務分析
    Banco Bilbao Vizcaya Argentaria SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bilbao Vizcaya Argentaria SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • AS Kevelt-製薬・医療分野:企業M&A・提携分析
    Summary AS Kevelt (Kevelt), a subsidiary of Pharmsynthez is a healthcare company that develops, manufactures and markets drug products. The company offers products which include concentrate solutions for infusion, endocervical gel, eye drops and other solutions. It also offers sub-contracting and di …
  • Avaya Inc.:戦略・SWOT・企業財務分析
    Avaya Inc. - Strategy, SWOT and Corporate Finance Report Summary Avaya Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • GlaxoSmithKline Plc (GSK):医療機器:M&Aディール及び事業提携情報
    Summary GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervo …
  • Ceapro Inc (CZO):製薬・医療:M&Aディール及び事業提携情報
    Summary Ceapro Inc (Ceapro) is a biotechnology company which develops proprietary extraction technologies for use in the production of extracts and active ingredients from oats and other renewable plant resources. The company’s extracts are also used in nutraceutical, cosmeceutical, and therapeutics …
  • Motor Oil (Hellas) Corinth Refineries SA (MOH):企業の財務・戦略的SWOT分析
    Motor Oil (Hellas) Corinth Refineries SA (MOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Bausch & Lomb Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Valeant Pharmaceuticals International Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆